Identification of Fat Mass and Obesity Associated (FTO) Protein Expression in Cardiomyocytes: Regulation by Leptin and Its Contribution to Leptin-Induced Hypertrophy

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Gan, Xiaohong Tracey ^a   Zhao, Ganjian ^a   Huang, Cathy X ^a   Rowe, Adrianna C ^a   Purdham, Daniel M ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CATHEPSIN L; CUX1 PROTEIN; FTO PROTEIN; ISOPROTEIN; JANUS KINASE 2; LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR ANTIBODY; P110CUX1 PROTEIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FTO GENE; GENE; GENE SILENCING; HEART HYPERTROPHY; HEART MUSCLE CELL; NEWBORN; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CATHEPSIN L; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; JANUS KINASE 2; LEPTIN; MALE; MYOCYTES, CARDIAC; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84883394714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074235     Document Type: Article

References (27)

1. Larder R, Cheung MK, Tung YC, Yeo GS, Coll AP, (2011) Where to go with FTO? Trends Endocrinol Metab. 22: 53-59.
2. Tung YC, Yeo GS, (2011) From GWAS to biology: lessons from FTO. Ann N Y Acad Sci 1220: 162-171.
3. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, et al. (2009) Inactivation of the Fto gene protects from obesity. Nature 458: 894-898.
4. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316: 889-894.
5. Dina C, Meyre D, Gallina S, Durand E, Körner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39: 724-726.
6. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3: e115, 2007.
7. Church C, Moir L, McMurray F, Girard C, Banks GT, et al. (2010) Overexpression of Fto leads to increased food intake and results in obesity. Nat Genet 42: 1086-1092.
8. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318: 1469-1472.
9. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161.
10. Wang P, Yang FJ, Du H, Guan YF, Xu TY, et al. (2011) Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction. Mol Med 17: 523-532.
11. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A, (2007) Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med 17: 206-211.
12. Sweeney G, (2010) Cardiovascular effects of leptin. Nat Rev Cardiol 7: 22-29.
13. Hou N, Luo JD, (2011) Leptin and cardiovascular diseases. Clin Exp Pharmacol Physiol 38: 905-913.
14. Purdham DM, Rajapurohitam V, Zeidan A, Huang C, Gross GJ, et al. (2008) A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. Am J Physiol Heart Circ Physiol 295: H441-H446.
15. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A, (2008) Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 79: 279-286.
16. Peters T, Ausmeier K, Rüther U, (1999) Cloning of Fatso (Fto), a novel gene deleted by the Fused toes (Ft) mouse mutation. Mamm Genome 10: 983-986.
17. Ahmad T, Chasman DI, Mora S, Paré G, Cook NR, et al. (2010) The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J 160: 1163-1169.
18. Loos RJ, Bouchard C, (2008) FTO: the first gene contributing to common forms of human obesity. Obes Rev 9: 246-250.
19. Tung YC, Ayuso E, Shan X, Bosch F, O'Rahilly S, et al. (2010) Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS One 5: e8771.
20. Maffei M, Halaas JL, Ravussin E, Pratley RE, Lee GH, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155-1161.
21. Villanueva EC, Myers MG Jr, (2008) Leptin receptor signaling and the regulation of mammalian physiology. Int J Obes (Lond) 32Suppl 7: S8-12.
22. Wauman J, Tavernier J, (2011) Leptin receptor signaling: pathways to leptin resistance Front Biosci. 16: 2771-2793.
23. Martinez-Abundis E, Rajapurohitam V, Haist JV, Gan XT, Karmazyn M, (2012) The obesity-related peptide leptin sensitizes cardiac mitochondria to calcium-induced permeability transition pore opening and apoptosis. PLoS One 7: e41612.
24. Stratigopoulos G, LeDuc CA, Cremona ML, Chung WK, Leibel RL, (2011) Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J Biol Chem 286: 2155-2170.
25. Hulea L, Nepveu A (20123) CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases. Gene 497: 18-26.
26. Rajapurohitam V, Izaddoustdar F, Martinez-Abundis E, Karmazyn M, (2012) Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation. Cell Signal 24: 2283-2290.
27. Frey N, Katus HA, Olson EN, Hill JA, (2004) Hypertrophy of the heart: a new therapeutic target? Circulation 109: 1580-1589.